Community Pharmacy, Athens, Greece.
Kings College London, Institute of Pharmaceutical Science, London, UK.
Hormones (Athens). 2021 Jun;20(2):347-358. doi: 10.1007/s42000-020-00253-3. Epub 2020 Oct 29.
The aim of this study was to evaluate the level of adoption of and adherence to the Hellenic Diabetes Association (HDA) guidelines for the management of individuals with type 2 diabetes mellitus (T2DM) by Greek physicians.
We used a constructed questionnaire distributed to physicians in Greece. The questionnaire assessed the adoption of and adherence to the general and treatment guidelines of the HDA, as well as factors affecting physicians' prescribing habits and demographic characteristics of the participating healthcare professionals. Factors affecting the preferred therapy or glycated hemoglobin target setting were evaluated using non-parametric tests. The likelihood of adherence was estimated by logistic regression models.
Adoption of the HDA guidelines was reported by 92.2% of physicians. Adherence to the treatment algorithm was reported by 53.5% and to the general HDA guidelines by 42.0% of healthcare professionals; overall adherence to both general and treatment guidelines was 26.1%. Multivariate analysis demonstrated that the likelihood of adherence to treatment guidelines was higher among individuals attending over five in comparison with those attending under two diabetes seminars per year (p = 0.037); in contrast, years of work (professional experience ≥ 21 vs. ≤ 5 years) affected adherence negatively (p = 0.031). No significant association was found between other parameters and adherence to either general or overall guidelines.
Adoption rates of the guidelines for the management of T2DM were high, while adherence rates to general and treatment guidelines were low. The rate of seminar attendance affected treatment adherence positively, while long professional practice affected treatment adherence negatively.
本研究旨在评估希腊医生对 2 型糖尿病(T2DM)患者管理的希腊糖尿病协会(HDA)指南的采用和依从程度。
我们使用了一份构建好的问卷,分发给希腊的医生。该问卷评估了医生对 HDA 的一般和治疗指南的采用和依从程度,以及影响医生处方习惯的因素和参与医疗保健专业人员的人口统计学特征。使用非参数检验评估影响首选治疗或糖化血红蛋白目标设定的因素。通过逻辑回归模型估计依从的可能性。
92.2%的医生报告采用了 HDA 指南。53.5%的医生报告了治疗算法的依从性,42.0%的医生报告了一般 HDA 指南的依从性;总体上,对一般和治疗指南的依从性为 26.1%。多变量分析表明,与每年参加两次以下糖尿病研讨会的医生相比,每年参加五次以上研讨会的医生更有可能遵守治疗指南(p=0.037);相比之下,工作年限(专业经验≥21 年与≤5 年)对依从性有负面影响(p=0.031)。其他参数与一般或总体指南的依从性之间没有发现显著关联。
T2DM 管理指南的采用率较高,而一般和治疗指南的依从率较低。研讨会参加率对治疗依从性有积极影响,而专业实践时间长则对治疗依从性有负面影响。